Can-Fite Announces Preparation for End-of-Phase II Meeting with FDA to Initiate the Phase III Liver Cancer Study for Namodenoson

Media coverage

• Title	Can-Fite Announces Preparation for End-of-Phase II Meeting with FDA to Initiate the Phase III Liver Cancer Study for Namodenoson
  Media name/outlet	Plus Company Updates (PCU)
  Country/Territory	United States
  Date	7/05/19
  Persons	Josep Llovet